Compare KURA & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KURA | DMLP |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | KURA | DMLP |
|---|---|---|
| Price | $10.36 | $22.36 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 198.6K |
| Earning Date | 11-04-2025 | 02-19-2026 |
| Dividend Yield | N/A | ★ 14.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.13 |
| Revenue | $104,029,000.00 | ★ $143,803,000.00 |
| Revenue This Year | $138.16 | N/A |
| Revenue Next Year | $66.98 | N/A |
| P/E Ratio | ★ N/A | $19.87 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.41 | $20.85 |
| 52 Week High | $12.49 | $34.88 |
| Indicator | KURA | DMLP |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 48.36 |
| Support Level | $9.68 | $21.88 |
| Resistance Level | $11.28 | $22.30 |
| Average True Range (ATR) | 0.49 | 0.50 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 42.50 | 51.04 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.